This year’s conference brings together entrepreneurs, professionals, policymakers, and thought leaders of the healthcare industry to discuss the groundbreaking advances that are reshaping healthcare.
As our understanding of human biology and disease have dramatically improved, we now approach the tipping point of being able to truly impact prevalent diseases.
With the theme, "At the Tipping Point: Transforming the Care of Prevalent Disease," the 22nd annual conference delves into the transformative tools, technologies, and approaches that are allowing us to tackle diseases affecting millions, such as obesity, neurodegeneration, and age-related conditions.
Keynote Speakers
Dr. John Maraganore
Founding CEO
Alnylam Pharmaceuticals
Javier Rodriguez
CEO
DaVita